Cargando…
Radiation for hematologic malignancies: from cell killing to immune cell priming
Over the past half-century, the role of radiotherapy has been revolutionized, in part, by a shift from intent to directly kill cancer cells to the goal of priming anti-tumor immune responses that attack both irradiated and non-irradiated tumors. Stimulation of anti-tumor immunity depends on the inte...
Autores principales: | Dabaja, Bouthaina, Spiotto, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299853/ https://www.ncbi.nlm.nih.gov/pubmed/37384297 http://dx.doi.org/10.3389/fonc.2023.1205836 |
Ejemplares similares
-
Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy
por: Fang, Penny Q., et al.
Publicado: (2021) -
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
por: Yahalom, Joachim, et al.
Publicado: (2020) -
Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies
por: Zuo, Fengli, et al.
Publicado: (2022) -
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report
por: Kahn, Jenna M., et al.
Publicado: (2021) -
The Basic Biology of PP2A in Hematologic Cells and Malignancies
por: Haesen, Dorien, et al.
Publicado: (2014)